La bourse est fermée
  • CAC 40

    5 609,15
    +34,79 (+0,62 %)
     
  • Euro Stoxx 50

    3 539,27
    +22,17 (+0,63 %)
     
  • Dow Jones

    30 218,26
    +248,74 (+0,83 %)
     
  • EUR/USD

    1,2127
    -0,0022 (-0,18 %)
     
  • Gold future

    1 842,00
    +0,90 (+0,05 %)
     
  • BTC-EUR

    15 778,70
    +62,93 (+0,40 %)
     
  • CMC Crypto 200

    365,19
    -14,05 (-3,71 %)
     
  • Pétrole WTI

    46,09
    +0,45 (+0,99 %)
     
  • DAX

    13 298,96
    +46,10 (+0,35 %)
     
  • FTSE 100

    6 550,23
    +59,96 (+0,92 %)
     
  • Nasdaq

    12 464,23
    +87,05 (+0,70 %)
     
  • S&P 500

    3 699,12
    +32,40 (+0,88 %)
     
  • Nikkei 225

    26 751,24
    -58,13 (-0,22 %)
     
  • HANG SENG

    26 835,92
    +107,42 (+0,40 %)
     
  • GBP/USD

    1,3438
    -0,0015 (-0,11 %)
     

Half-year report on the liquidity contract between Safe Orthopaedics and Louis Capital Markets

Safe Orthopaedics
·8 min de lecture

Eragny-sur-Oise, France, July 30, 2020 – 18h00 CEST – Safe Orthopaedics (FR0013467123 - ALSAF), a company specializing in the design and marketing of ready-to-use technologies for spinal surgeries, delivering the safest treatment of spinal fractures urgently treated, is today releasing its half-year report on the liquidity contract signed with Louis Capital Markets on June 1, 2018.

The liquidity account had the following holdings as of June 30, 2020:

  • 1 012 shares

  • 364,57 euros

During the first half of 2020, the following have been negotiated:

PURCHASE

72 138 shares

9 771,00 euros

547 transactions

SALE

230 545 shares

9 894,38 euros

507 transactions


For the prior period (December 31, 2019), the corresponding figures were:

  • 159 419 shares

  • 1 623,33 euros

As of March 18, 2019 (implementation of the new liquidity contract), the followings were made available:

  • 74 738 shares

  • 7 561,33 euros

The detail of day-to-day activities is as follows:

Purchase

Sale

ALSAF FP

Trading volume

Number of shares

Cash (EUR)

Trading volume

Number of shares

Cash (EUR)

Total

547

72 138

9 771,00

507

230 545

9 894,38

20200101

0

0

0,00

0

0

0,00

20200102

2

4 391

39,52

1

1

0,01

20200103

2

3 891

32,69

1

1

0,01

20200106

1

1

0,01

1

1

0,01

20200107

1

1

0,01

11

38 511

401,57

20200108

10

37 031

437,66

2

2 851

38,77

20200109

2

2 981

32,79

2

4 871

58,45

20200110

1

1

0,01

2

4 821

57,85

20200113

1

1

0,01

11

35 411

478,84

20200114

1

1

0,02

11

27 411

434,21

20200115

5

15 491

240,57

7

15 771

280,75

20200116

1

1

0,02

2

1 961

34,51

20200117

1

610

1 604,30

1

91 599

1 602,98

20200120

9

172

391,58

4

33

80,45

20200121

11

183

391,24

1

1

2,30

20200122

6

85

159,97

2

21

41,57

20200123

8

118

203,93

2

31

57,44

20200124

1

1

1,80

11

230

418,10

20200127

6

94

169,59

2

21

39,89

20200128

4

58

98,89

5

88

161,02

20200129

6

96

160,69

4

71

125,62

20200130

6

96

155,51

2

21

35,70

20200131

4

58

93,22

5

88

147,89

20200203

5

76

122,44

2

21

35,14

20200204

1

1

1,64

4

81

132,76

20200205

4

60

93,19

3

41

65,84

20200206

5

78

122,04

2

21

34,23

20200207

3

38

58,66

4

81

131,22

20200210

4

60

90,85

2

21

32,65

20200211

5

78

115,20

1

1

1,50

20200212

4

61

87,87

9

201

309,91

20200213

6

111

168,65

2

21

33,60

20200214

5

81

119,80

1

1

1,50

20200217

6

101

145,54

1

1

1,50

20200218

6

99

134,36

2

31

44,33

20200219

4

59

79,65

5

111

158,92

20200220

5

80

108,29

5

111

163,17

20200221

5

80

105,69

1

1

1,36

20200224

11

215

250,70

1

1

1,28

20200225

5

159

183,77

5

141

169,99

20200226

5

70

80,48

2

41

49,20

20200227

5

203

226,77

3

71

83,64

20200228

6

72

78,59

1

1

1,11

20200302

4

49

49,70

7

221

243,52

20200303

3

24

24,32

4

109

114,45

20200304

4

51

50,72

1

1

1,03

20200305

8

137

124,96

1

1

0,96

20200306

6

79

66,02

1

1

0,87

20200309

1

1

0,78

1

1

0,78

20200310

5

76

53,94

2

51

37,59

20200311

3

170

119,98

8

531

391,42

20200312

8

144

98,22

6

157

125,57

20200313

5

86

55,55

2

31

20,97

20200316

10

236

141,21

5

90

60,78

20200317

4

44

24,96

6

94

57,73

20200318

9

101

55,75

5

74

49,72

20200319

7

178

106,56

9

208

137,28

20200320

6

50

29,00

4

371

229,34

20200323

4

34

20,40

4

50

31,45

20200324

1

1

0,66

10

154

101,02

20200325

4

50

30,80

2

2

1,29

20200326

3

33

19,49

4

48

30,91

20200327

3

33

19,28

3

20

12,20

20200330

2

21

12,20

4

48

28,93

20200331

4

51

29,24

2

23

13,49

20200401

1

1

0,59

11

154

94,19

20200402

11

106

88,69

3

37

34,86

20200403

5

60

42,09

3

45

33,89

20200406

3

24

16,79

15

309

230,75

20200407

4

36

25,79

3

29

21,62

20200408

4

36

25,19

4

36

27,00

20200409

3

31

21,01

4

36

25,92

20200410

0

0

0,00

0

0

0,00

20200413

0

0

0,00

0

0

0,00

20200414

4

44

29,73

1

1

0,70

20200415

3

29

19,54

11

115

84,96

20200416

1

1

0,72

11

106

77,19

20200417

6

64

50,96

10

84

75,14

20200420

4

38

28,74

1

1

0,77

20200421

4

39

27,59

1

1

0,73

20200422

2

21

14,35

4

31

21,95

20200423

3

34

23,83

2

12

8,71

20200424

2

18

12,35

3

27

19,10

20200427

4

39

26,45

1

1

0,68

20200428

3

31

21,03

4

33

23,33

20200429

3

31

21,35

4

33

23,78

20200430

4

48

33,01

1

1

0,71

20200501

0

0

0,00

0

0

0,00

20200504

6

83

56,02

1

1

0,68

20200505

3

28

18,96

2

17

12,03

20200506

4

53

35,48

1

1

0,69

20200507

1

1

0,68

11

131

96,28

20200508

4

31

21,37

3

23

16,51

20200511

4

32

21,69

2

16

11,20

20200512

9

108

68,11

1

1

0,67

20200513

3

25

15,43

11

130

89,35

20200514

9

115

67,75

4

31

20,65

20200515

3

27

15,52

3

27

16,13

20200518

4

35

19,93

2

18

10,61

20200519

4

33

19,21

1

1

0,60

20200520

4

32

18,29

1

1

0,58

20200521

4

32

18,22

2

20

11,77

20200522

4

32

17,97

2

20

11,62

20200525

3

25

13,82

4

39

22,52

20200526

1

1

0,57

6

68

40,60

20200527

4

32

19,19

3

28

17,57

20200528

4

30

17,98

2

15

9,33

20200529

4

32

19,21

1

1

0,62

20200601

1

1

0,61

10

128

81,10

20200602

1

1

0,67

9

145

101,32

20200603

11

257

165,81

4

53

37,10

20200604

5

91

55,03

4

57

35,50

20200605

5

121

71,17

2

11

6,69

20200608

5

81

46,77

2

31

18,38

20200609

1

1

0,60

10

217

134,12

20200610

5

101

60,08

6

97

60,36

20200611

5

111

65,15

4

56

34,13

20200612

2

31

17,68

8

139

82,75

20200615

1

1

0,57

4

56

32,60

20200616

4

91

52,07

2

21

12,31

20200617

4

91

51,66

10

161

99,46

20200618

9

203

110,33

1

1

0,57

20200619

6

137

73,08

1

1

0,54

20200622

5

81

42,07

5

111

60,02

20200623

5

87

44,50

3

33

17,59

20200624

1

1

0,54

9

199

108,77

20200625

5

81

43,48

4

58

32,42

20200626

8

122

63,09

5

78

42,45

20200629

4

59

29,88

6

109

57,63

20200630

5

77

39,07

1

1

0,51

Next financial release:

First semester 2020 results, September 28th, 2020 (post-market)

About Safe Orthopaedics

Founded in 2010, Safe Orthopaedics is a French medical technology company, a pioneer of the design and marketing of innovative ready-to-use technologies (single-use implants and instruments) for spinal diseases, delivering the safest treatment of spinal fractures. The technologies include sterile implants and ready-to-use instruments available to the surgeon at any time and anywhere, enabling minimally invasive approaches, reducing the risks of cross contamination and infection in the interest of the patient. Protected by 17 patent families, the SteriSpineTM Kits are CE marked, FDA and CFDA approved. Safe Orthopaedics, has its headquarter close to Paris (95610 Eragny-Sur-Oise - France) and has created a subsidiary in the UK, Germany and in the US, employing around 50 employees for a total sales of 4.7M€ in 2019. For more information : www.SafeOrthopaedics.com


Contacts

Safe Orthopaedics
François-Henri Reynaud
Chief Financial Officer
Tél. : +33 (0)1 34 21 50 00
investors@safeorthopaedics.com

Press Relations
Ulysse Communication
Bruno Arabian / +33 (0)6 87 88 47 26 / barabian@ulysse-communication.com
Nicolas Daniels / +33 (0)6 63 66 59 22 / ndaniels@ulysse-communication.com

Attachment